Rare diseases affect one in 17 people in the UK, but a Government initiative designed to improve their quality of life will ...

DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...

Berikut adalah penjelasan tentang tips dan cara menaikkan trombosit pada anak, makanan yang harus dihindari, serta supplemen ...

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer ... (ITP) that it acquired via ...

I also didn’t have any bruising or active bleeding, all signs that would ... Today, Kristy is excited to join the Rare Disease Advisor team “to provide support to those who may need it and help fellow ...

A team of international scientists has developed a method to predict the risk of developing cancer from a blood disorder common in older adults, according to a study published in the journal Blood.

Did you know that donating blood can do more than just save a life? Here's what your blood can tell you about your health.

Type 1, not type 2 diabetes, is autoimmune. There are other rarer autoimmune types. Learn about type 2 diabetes, immunity, ...